B-cell neoplasm
Clinical trials for B-cell neoplasm explained in plain language.
Never miss a new study
Get alerted when new B-cell neoplasm trials appear
Sign up with your email to follow new studies for B-cell neoplasm, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope: drug combo targets HIV-Linked cancers
Disease control Recruiting nowThis early-stage trial tests whether adding the drug pomalidomide to standard chemotherapy (with or without rituximab) is safe and effective for people with HIV who have aggressive B-cell non-Hodgkin lymphoma. About 25 adults with high-risk features will receive up to 6 cycles of…
Matched conditions: B-CELL NEOPLASM
Phase 1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Aug 27, 2026 00:00 UTC
-
New CAR-T therapy targets tough childhood cancers
Disease control Recruiting nowThis phase 2 trial is testing a new type of CAR-T cell therapy called MB-CART2019.1 in children and teens (ages 6 months to under 18) with B-cell cancers that have come back or not responded to standard treatments. The therapy uses the patient's own immune cells, modified to atta…
Matched conditions: B-CELL NEOPLASM
Phase 2 • Sponsor: Miltenyi Biomedicine GmbH • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC